Integrative Therapeutics introduces HPA Axis Optimization Program

March 28, 2014 — From the makers of Cortisol Manager comes a new suite of neuroendocrine products designed to support optimal hypothalamic-pituitary-adrenal (HPA) axis function.*

The HPA axis is the central part of the neuroendocrine system that controls the stress response. Because the impact of stress is individualized and varied in its outcome, thorough practitioner analysis of each patient is critical.

Integrative Therapeutics has designed their new HPA Axis Optimization Program to help healthcare professionals accurately assess common and complex symptoms within various stress response stages — thereby improving patients’ ability to respond and adapt to stressful stimuli while promoting energy recovery and restorative sleep.*

“Although Cortisol Manager continues to be our most-utilized option for early-stage stress resistance, our research and development team has identified several key nutrients for supporting patients experiencing mid- and late-stage symptoms,” explains Mandy Kraynik, vice president of Integrative Therapeutics.

Patients in the mid-stage of the stress response can benefit from a targeted non-stimulating adaptogen formula to support the body’s ability to respond to stress via the HPA axis.* Whereas patients in the late-stage of the stress response benefit from adrenal-supportive supplementation to support healthy cortisol production and often require unique nutrients to support a restorative sleep cycle.*

Based on these findings, Integrative has added HPA Adapt, CortiVive, and Sleep Reset to their neuroendocrine portfolio. For more information on these products and the HPA Axis Optimization Program, visit integrativepro.com.

*This statement has not been evaluated by the food and drug administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Source: Integrative Therapeutics